Skip to content

GILEAD SCIENCES, INC.

GILD

CIK 0000882095

← back to feed
Revenue (TTM)
$28.48B
+2.4% YoY Q1 Apr 2026
Net Income (TTM)
$8.35B
+1,672.9% YoY Q1 Apr 2026
EPS Diluted (TTM)
$6.64
+1,684.2% YoY Q1 Apr 2026
Gross Margin
20.8%
Q1 Apr 2026
Operating Margin
37.3%
Q1 Apr 2026
Net Margin
29.3%
Q1 Apr 2026
Free Cash Flow (TTM)
$7.83B
Q1 Apr 2026
Cash
$5.41B
Q1 Apr 2026
Total Debt
$22.17B
Q1 Apr 2026
Shares Outstanding
1.24B sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings